These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong. Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248 [Abstract] [Full Text] [Related]
12. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects]. Girling DJ. Bull Int Union Tuberc; 1974 Jun; 49(1):451-5. PubMed ID: 4619567 [No Abstract] [Full Text] [Related]
14. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, Tall R, Fox W. Br Med J; 1972 Mar 25; 1(5803):765-71. PubMed ID: 4259217 [Abstract] [Full Text] [Related]
16. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis]. Donomae I, Fujita S, Gomi J, Hibino S, Horai Z. Kekkaku; 1971 Sep 25; 46(9):371-7. PubMed ID: 4330662 [No Abstract] [Full Text] [Related]
18. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland. Zierski M. Scand J Respir Dis Suppl; 1978 Sep 25; 102():48-52. PubMed ID: 278215 [No Abstract] [Full Text] [Related]